November | December 2009
 |
|
MedEsthetics Southern Africa, a franchise publication of MedEsthetics magazine, has been chosen as the official journal of the Aesthetic & Anti-Aging Medicine Society of South Africa (AAMSSA)
. |
|
Syneron and Candela Join Forces
Syneron Medical and Candela Corporation have entered into a definitive agreement to combine their companies in an all-stock transaction. Under the agreement—unanimously approved by the Boards of Directors of both companies—Syneron will pay 0.2911 for each share of Candela for a total consideration of approximately $65 million. The transaction is expected to be complete by the end of 2009. “The combination of Syneron and Candela brings together two well-respected industry leaders in aesthetic medical devices,” said Louis P. Scafuri, CEO of Syneron. “The product portfolio and commercial infrastructure of Syneron and Candela are highly complementary. The combined company will be extremely well positioned to benefit from an improving macroeconomic climate.”
Following the close of the transaction, Scafuri will remain CEO of the combined company and Gerard E. Puorro will join Syneron’s board of directors. The management team for the combined company will be comprised of executives from each organization.
Biopelle Acquires PRESCRIBEDsolutions
Biopelle, a Ferndale Pharma Company, has announced its acquisition of PRESCRIBEDsolutions. Launched in 2004, PRESCRIBEDsolutions is a customizable skincare line offered through dermatologists and plastic surgeons. “The PRESCRIBEDsolutions brand fits with our brands as a standalone, innovative system of skincare, as well as providing individual unique products within the line that Biopelle had been lacking,” said Elliott Milstein, president of Biopelle. “The addition of PRESCRIBEDsolutions completes Biopelle’s goal of becoming a one-stop-shop for the dispensing aesthetic physician.”
Bayer HealthCare Acquires Two SkinMedica Lines
Intendis, part of Bayer HealthCare, has signed an agreement to acquire Desonate—a low potency topical corticosteroid—and NeoBenz Micro—a benzoyl peroxide medication—from SkinMedica. Under the agreement, which is pending regulatory approval, Intendis will acquire all commercial rights, including assigned contracts and intellectual property related to the two lines.
DermaQuest Celebrates 10th Anniversary
DermaQuest, makers of DermaLash, Peptide Mobilizer and Revive Eye Firm, is celebrating its 10th anniversary. “The advances in technology have truly motivated me and continue to keep DermaQuest ahead of the curve,” said founder and cosmetic chemist Sam Dhatt. “Skincare has come so far. I was one of the first chemists to work with glycolic acid back in the early 1990s and to formulate with peptides, now we’ve begun working with stem cells. It is truly unbelievable how far we have come, and I can’t wait to see what tomorrow will bring in this ever-changing industry.” As part of its 10-year celebration, the company has launched its newest line, the DermaMinerals mineral makeup line.
Medicis and Revance in Neurotoxin Agreement
Medicis Pharmaceutical and Revance Therapeutics have entered into a license agreement granting Medicis worldwide aesthetic and dermatological rights to Revance’s novel, investigational, injectable botulinum toxin A product (RT002) currently in preclinical studies. Under the terms of the agreement, Medicis will pay Revance $10 million at signing with additional milestone payments totaling approximately $94 million upon successful completion of certain clinical, regulatory and commercial milestones, plus a royalty-based payment on sales and supply price. Revance will retain certain therapeutic rights to the product. “We are very pleased to have reached this agreement with Medicis,” said Dan Browne, president and CEO of Revance. “Revance is committed to developing technology that has the potential to expand the aesthetic category through what we believe is a compelling pipeline of investigational botulinum toxin products that have favorable performance, safety and efficacy profiles.”
 |
|
David Giuliani
|
|
Clarisonic on Inc. magazine’s Top 500
Thanks to a staggering 2,197% growth in sales from 2005 to 2008, Clarisonic (Pacific Biosciences Laboratories) debuted at No. 60 on this year’s Inc. 500 list. The annual rankings compiled by Inc. magazine honor American business ingenuity and innovation by recognizing the most dynamic, fast-growth companies in the nation.
“Behind Clarisonic’s success are the many talented and hard working people on our team,” said Clarisonic inventor David Giuliani. “At a time when many companies are laying low and laying off, Clarisonic is revving up new products, expanding U.S. manufacturing and most importantly, hiring.” Headquartered in Seattle, the company is positioning itself for continued growth with a “Built in the USA” strategy—assembling products locally for optimal quality—and by reinvesting a significant percentage of its revenues in research and development.
Correction
In the September/October 2009 issue of MedEsthetics magazine Caroline Murata was incorrectly cited as a registered nurse in the article “Invisible Ink.” She is a medical esthetician.
Events
2009
November 5-8
Clinical Applications for Age Management Medicine, Red Rock Resort & Spa, Las Vegas. Contact: AAMG, 847.579.1088, www.agemed.org
November 7-8
International Esthetics, Cosmetics & Spa Conference, Broward County Convention Center, Ft. Lauderdale, Florida. Contact: www.iecsc.com
November 8-9
Dubai Congress on Anti-Aging & Aesthetic Medicine, Dubai World Trade Center, Dubai, UAE. Contact: anti-agingevents.com/dubai, www.worldhealth.net
December 3-6
Florida Society of Plastic Surgeons, The Fairmont Turnberry Isle Resort & Club, Miami. Contact: Wanda Callahan, 904.693.1799
December 4-6 Aesthetic Plastic Surgery: The Next Generation, The Waldorf Astoria Hotel, New York. Contact: The New York Academy of Medicine, Francine Leinhardt, 347.266.7887
December 9-12 17th Annual World Congress on Anti-Aging Medicine, Mandalay Bay Hotel & Casino, Las Vegas. Contact: 888.997.0112, www.worldhealth.net
2010
January 9-13
32nd Annual Oral & Maxillofacial Pathology Review, Hilton at the Walt Disney World Resort, Lake Buena Vista, FL. Contact: Conference Management, 305.663.1628, www.meccinc.com
January 14-18 South Beach Symposium, Loews Miami Beach Hotel, Miami. Contact: 904.309.6262, www.southbeachsymposium.org
January 15-17 First World Anti-Aging Congress Mexico, Mexico City. Contact: info@anti-agingevents.com, www.worldhealth.net
January 15-18 The 7thAnnual Orlando Dermatology Aesthetic & Clinical Conference, Peabody Orlando, Orlando, FL. Contact: 646.453.5720, www.orlandoderm.org
January 27-31
26thAnnual Scientific Meeting of the American Academy of Cosmetic Surgery (AACS), Rosen Shingle Creek Resort, Orlando, FL. Contact: 312.981.6760, www.cosmeticsurgery.org
January 29-31
Expanding Horizons: New Paradigms in Aesthetic Plastic Surgery, The Mirage, Las Vegas. Contact: ASPS/ASAPS, 847.228.9900, www.plasticsurgery.org
February 16-19 Egyptian Society of Plastic & Reconstructive Surgery Annual Meeting, Sharm Alsheikh Resort, Egypt. Contact: Fouad Ghareeb, esprs@yahoo.com, www.esprs.com
February 18-20 Aesthetics Facial Reconstruction in Adults & Children, JW Marriot Starr Pass Resort & Spa, Tucson, AZ. Contact: ASPS, 847.228.9900, www.plasticsurgery.org
February 20-21 Medical Aesthetics Conference & Expo, Los Angeles Convention Center, Los Angeles. Contact: 877.271.6789, www.spaandresortexpo.com
March 3-6 18th Annual Meeting of the Association of Dermatology Administrators/Managers (ADA-M), Hyatt Regency Miami, Miami. Contact: 866.480.3573, www.ada-m.org
March 5-9 68th Annual Meeting of the American Academy of Dermatology (AAD), Miami Beach Convention Center, Miami. Contact: 866.503.7546, www.aad.org
|
